Drug Discovery Platform is a place of research and development where medicines are identified for various diseases. Presently, drug discovery platform boosts up with digital technology that makes the work more easy and efficient. Cloud management, among the digital technologies is a millstone for drug discovery platform. Since, cloud management release the load of huge data and provides easy actability to the researcher in drug discovery platform, currently is a most acceptable technology has been adopted by significant number of drug discovery platform that is called cloud-based drug discovery platform. This platform helps customers overcome many challenges by leveraging a network of web and mobile-accessible applications for instance, it provides secure and collaborative project management and the ability to share project information. Moreover, the cloud-based drug discovery platform is enough flexible to deal with any types of research and development platform, through this customization users can create their own pipeline or protocol. Currently, cloud-based drug discovery platform is getting more developed by adding more features such as publishing and sharing services. Cloud-based drug discovery platform is accessible by computers, notebook and mobile as well. Cloud-based drug discovery platform is secure and can be maintained by a third party as well. For all these benefits, the cloud-based drug discovery platform market is anticipated to grow at a significant rate in terms of value.
On the basis of types of services cloud-based drug discovery platform market I segmented into Infrastructure as a Service (IaaS), Platform as a Service (PaaS) and Software as a Service (SaaS). IaaS offers data-center space, and servers, network equipment such as software for businesses and routers/switches. PaaS offers full hardware architecture and software framework. In SaaS process providers allow to access software over the net only.
Geographically, global cloud-based drug discovery market is segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa. North America, Western Europe are the major shareholder of cloud-based drug discovery platform market. Asia pacific market for cloud-based drug discovery platform is expected to fuel the cloud-based drug discovery platform market in the near future.
Data management is a critical issue for the pharmaceutical industry. The pharmaceutical industry is rapidly restructuring its discovery business model to completely networked and integrated research and development in order to manage the huge data. This big data concept is main growth driver for the cloud-based drug discovery platform market. Graphical representation is a dynamic and quick form of getting a result which is easy for decision making in a management level, understanding the demand of consumers, companies are offering cloud-based drug discovery platform accordingly. Cloud-based drug discover platform runts at zero lag time, that’s saves time for the users. This is another reason why pharmaceutical companies adopt cloud-based drug discover platform.
However, many companies do not what to keep their confidential data in the cloud storage of the service provider which is a restraining factor for the cloud-based drug discover platform market. Moreover, due to high maintenance cost many small and medium scale pharmaceutical companies do not like to enter into Cloud-Based Drug Discovery Platform.
Since, huge number of drug discovery centre are located in North America, Japan and Western Europe regions, these are the potential market for cloud-based drug discovery platform market. Many companies from this region already adopted and using cloud-based drug discovery platform, however the regions is not penetrated and have significant opportunities for cloud-based drug discovery platform market.
Some of the key players operating in the cloud-based drug discovery platform market IBM Corp, Accenture PLC, BioXcel Corporation, Cloud Pharmaceuticals, Inc., WuXi AppTec (Shanghai) Co., Ltd., dassault systèmes biovia ltd.
A Sample of this Report is Available Upon Request @http://www.persistencemarketresearch.com/samples/11020
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Request to View Tables of Content @ http://www.persistencemarketresearch.com/toc/11020